Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] Forty Years Since Diamond v. Chakrabarty: Legal Underpinnings and its Impact on the Biotechnology Industry and Society

Posted on: January 29, 2021May 13, 2026Biotech , Patent Law

CPIP has published a new policy brief celebrating the fortieth anniversary of the Diamond v. Chakrabarty decision, where the Supreme Court in 1980 held that a genetically modified bacteria was […]

[Archived Post] New CPIP Policy Brief: The Long Shadow of the Blackberry Shutdown That Wasn’t

Posted on: July 28, 2020May 13, 2026Innovation , Patent Law

CPIP has published a new policy brief by CPIP Senior Fellow for Innovation Policy Jonathan Barnett entitled The Long Shadow of the Blackberry Shutdown That Wasn’t. The policy brief looks […]

[Archived Post] “No Combination Drug Patents Act” Stalls, but Threats to Innovation Remain

Posted on: June 27, 2019May 13, 2026Biotech , Patents , Pharma

By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of […]

[Archived Post] Department of Justice Recognizes Importance of Reliable Patent Rights in Innovation Economy

Posted on: April 23, 2018May 13, 2026Antitrust , Patent Licensing

It is undeniable that the patent system has been under stress for the past decade, as courts, regulators, and even the Patent Office itself (as the newly confirmed Director Andrei […]

[Archived Post] CPIP Co-Founder Testifies at House Judiciary Committee Hearing on IP

Posted on: June 13, 2017May 13, 2026Innovation , Legislation , Patent Law

CPIP co-founder Adam Mossoff testified on June 13 before the House Judiciary Committee’s subcommittee on the Courts, Intellectual Property and the Internet.  He and other witnesses testified about the impact […]

[Archived Post] Lobbyists Continue to Invoke Discredited Junk Science to Push Patent Legislation

Posted on: March 28, 2017May 13, 2026Uncategorized

It seems no matter how many times the mole gets whacked, it keeps popping back up. The latest incarnation of this problem is a recent op-ed by Katie Johnson of […]

[Archived Post] CPIP Scholars Ask Supreme Court to Resist Call to Restrict Venue Choices for Patent Owners

Posted on: March 9, 2017May 13, 2026Innovation , Patent Litigation

On March 8, 2017, CPIP Scholars Adam Mossoff, Devlin Hartline, Chris Holman, Sean O’Connor, Kristen Osenga, & Mark Schultz joined an amicus brief in TC Heartland v. Kraft Foods. CPIP […]

[Archived Post] Law Professors & Economists Urge Caution on VENUE Act in Letter to Congress

Posted on: August 1, 2016May 13, 2026Innovation , Legislation , Patent Law , Patent Litigation , Uncategorized

Today, 28 law professors, economists, and political scientists from across the nation submitted a letter to Congress expressing serious concerns about the recent push for sweeping changes to patent litigation […]

[Archived Post] Do As I Say, Not As I Do: Google’s Patent Transparency Hypocrisy

Posted on: June 30, 2016May 13, 2026Innovation , Inventors , Patent Law , Statistics , Uncategorized

It is common today to hear that it’s simply impossible to search a field of technology to determine whether patents are valid or if there’s even freedom to operate at […]

[Archived Post] Changes to Patent Venue Rules Risk Collateral Damage to Innovators

Posted on: March 22, 2016May 13, 2026Innovation , Inventors , Legislation , Patent Law , Patent Litigation , Uncategorized

By Devlin Hartline Advocates for changing the patent venue rules, which dictate where patent owners can sue alleged infringers, have been arguing that their remedy will cure the supposed disease […]

Posts pagination

Page 1 Page 2 Next page

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes